Yala stablecoin YU shows suspicious activity similar to USDX
According to ChainCatcher, the DeFi community YAM posted on X stating that they have observed warning signs with the Yala stablecoin YU. An address closely related to Yala is borrowing the full amount of USDC and most of the YU funds from the Yala Frontier market on Euler. Despite persistently high interest rates, there has been no repayment activity.
Currently, the market's fund utilization rate has reached 100%, which means lenders are unable to withdraw any liquidity. The Euler team has also set the borrowing cap for the Yala market on Frontier to zero. Reportedly, the Yala team has not responded to either the Euler team or Discord community users. YAM further added that YU is still maintaining its peg on Solana, and there is still nearly one million USDC in its liquidity pool available for exit at the pegged price. This article is mainly a risk warning, and it is not yet certain whether Yala is truly in trouble.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Iranian President will head to New York for UN meeting
"Big Short" Burry opens a position in QXO (QXO.US), betting on building products integration and undervaluation; stock price rises over 7%
Investor Michael Burry disclosed that he has purchased common and preferred shares of QXO (QXO.US), a building products company, citing its integration strategy and the currently depressed stock price. The stock surged 7.2% on Monday.
700,000 new elderly patients join, Eli Lilly (LLY.US) dominates 70%: The first Medicare weight loss drug coverage report released
Dave Ricks, CEO of Eli Lilly (LLY.US), said in an interview on Monday that since Medicare began coverage for obesity drugs in July, 700,000 new elderly patients have started using GLP-1 medications.
Market Is Primed for a ‘Face Ripper' Rally Thanks to Four Ingredients Says Tom Lee
